InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Doyle Thomas James. Insider active across 1 company, notably Kura Oncology, Inc.. Aggregated, 11 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €51k. History available since 7 February 2022. The latest transaction was disclosed on 27 January 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Doyle Thomas James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
2,226 shares@ US$8.460731.0% of flowCommon StockSEC:0001193125-26-025302:0
21,250 shares0Common StockSEC:0001193125-26-004569:0
24,967 shares0Common StockSEC:0001193125-25-283562:0
24,966 shares0Common StockSEC:0001193125-25-223662:0
2,241 shares@ US$7.871947.8% of flowCommon StockSEC:0000950170-25-010137:0
21,250 shares0Common StockSEC:0000950170-25-002072:0
594 shares@ US$17.800527.6% of flowCommon StockSEC:0000950170-24-009496:0
21,250 shares0Common StockSEC:0000950170-24-001850:0
10,625 shares0Common StockSEC:0001209191-23-011289:0
682 shares@ US$13.889824.6% of flowCommon StockSEC:0001209191-23-005746:0
8,390 shares0Common StockSEC:0001209191-22-008156:0
11 of 11 declarations
About Doyle Thomas James
DOYLE THOMAS JAMES is an insider associated with Kura Oncology, Inc. (XNAS), where the listed role is SVP, Finance & Accounting. Across 8 filings in total, the 8 sampled filings span from 2022-02-09 to 2025-01-28 and show 0 EUR of buys and 35335 EUR of sells, with the transaction nature listed as Attribution.
